RESUMEN
Acetylcholinesterase (AChE), a key enzyme in the central and peripheral nervous systems, is the principal target of organophosphorus nerve agents. Quaternary oximes can regenerate AChE activity by displacing the phosphyl group of the nerve agent from the active site, but they are poorly distributed in the central nervous system. A promising reactivator based on tetrahydroacridine linked to a nonquaternary oxime is also an undesired submicromolar reversible inhibitor of AChE. X-ray structures and molecular docking indicate that structural modification of the tetrahydroacridine might decrease inhibition without affecting reactivation. The chlorinated derivative was synthesized and, in line with the prediction, displayed a 10-fold decrease in inhibition but no significant decrease in reactivation efficiency. X-ray structures with the derivative rationalize this outcome. We thus show that rational design based on structural studies permits the refinement of new-generation pyridine aldoxime reactivators that may be more effective in the treatment of nerve agent intoxication.
Asunto(s)
Reactivadores de la Colinesterasa/química , Reactivadores de la Colinesterasa/farmacología , Agentes Nerviosos/toxicidad , Relación Estructura-Actividad , Acetilcolinesterasa/química , Acetilcolinesterasa/metabolismo , Animales , Dominio Catalítico , Cristalografía por Rayos X , Evaluación Preclínica de Medicamentos/métodos , Proteínas de Peces/química , Proteínas de Peces/metabolismo , Humanos , Simulación del Acoplamiento Molecular , Agentes Nerviosos/química , Cloruro de Obidoxima/farmacología , Compuestos Organofosforados/química , Compuestos Organofosforados/toxicidadRESUMEN
Organophosphorus nerve agents (OPNAs) are highly toxic compounds that represent a threat to both military and civilian populations. They cause an irreversible inhibition of acetylcholinesterase (AChE), by the formation of a covalent P-O bond with the catalytic serine. Among the present treatment of nerve agents poisoning, pyridinium and bis-pyridinium aldoximes are used to reactivate this inhibited enzyme but these compounds do not readily cross the blood brain barrier (BBB) due to their permanent cationic charge and thus cannot efficiently reactivate cholinesterases in the central nervous system (CNS). In this study, a series of seven new uncharged oximes reactivators have been synthesized and their in vitro ability to reactivate VX and tabun-inhibited human acetylcholinesterase (hAChE) has been evaluated. The dissociation constant K(D) of inhibited enzyme-oxime complex, the reactivity rate constant kr and the second order reactivation rate constant k(r2) have been determined and have been compared to reference oximes HI-6, Obidoxime and 2-Pralidoxime (2-PAM). Regarding the reactivation of VX-inhibited hAChE, all compounds show a better reactivation potency than those of 2-PAM, nevertheless they are less efficient than obidoxime and HI-6. Moreover, one of seven described compounds presents an ability to reactivate tabun-inhibited hAChE equivalent to those of 2-PAM.
Asunto(s)
Acetilcolinesterasa/metabolismo , Sustancias para la Guerra Química/toxicidad , Inhibidores de la Colinesterasa/toxicidad , Reactivadores de la Colinesterasa/síntesis química , Reactivadores de la Colinesterasa/farmacología , Compuestos Organofosforados/toxicidad , Reactivadores de la Colinesterasa/química , Evaluación Preclínica de Medicamentos , Electroquímica , Proteínas Ligadas a GPI/metabolismo , Humanos , Estructura Molecular , Cloruro de Obidoxima/farmacología , Oximas/síntesis química , Oximas/química , Oximas/farmacología , Compuestos de Pralidoxima/farmacología , Compuestos de Piridinio/farmacología , Proteínas Recombinantes/metabolismoRESUMEN
Tabun belongs to the most toxic nerve agents. Its mechanism of action is based on acetylcholinesterase (AChE) inhibition at the peripheral and central nervous systems. Therapeutic countermeasures comprise administration of atropine with cholinesterase reactivators able to reactivate the inhibited enzyme. Reactivation of AChE is determined mostly biochemically without specification of different brain structures. Histochemical determination allows a fine search for different structures but is performed mostly without quantitative evaluation. In rats intoxicated with tabun and treated with a combination of atropine and HI-6, obidoxime, or new oxime K048, AChE activities in different brain structures were determined using biochemical and quantitative histochemical methods. Inhibition of AChE following untreated tabun intoxication was different in the various brain structures, having the highest degree in the frontal cortex and reticular formation and lowest in the basal ganglia and substantia nigra. Treatment resulted in an increase of AChE activity detected by both methods. The highest increase was observed in the frontal cortex. This reactivation was increased in the order HI-6 < K048 < obidoxime; however, this order was not uniform for all brain parts studied. A correlation between AChE activity detected by histochemical and biochemical methods was demonstrated. The results suggest that for the mechanism of action of the nerve agent tabun, reactivation in various parts of the brain is not of the same physiological importance. AChE activity in the pontomedullar area and frontal cortex seems to be the most important for the therapeutic effect of the reactivators. HI-6 was not a good reactivator for the treatment of tabun intoxication.
Asunto(s)
Encéfalo/efectos de los fármacos , Reactivadores de la Colinesterasa/farmacología , Cloruro de Obidoxima/farmacología , Organofosfatos/antagonistas & inhibidores , Organofosfatos/toxicidad , Oximas/farmacología , Compuestos de Piridinio/farmacología , Acetilcolinesterasa/metabolismo , Animales , Atropina , Encéfalo/enzimología , Encéfalo/patología , Sustancias para la Guerra Química/toxicidad , Inhibidores de la Colinesterasa/administración & dosificación , Inhibidores de la Colinesterasa/toxicidad , Reactivadores de la Colinesterasa/administración & dosificación , Reactivadores de la Colinesterasa/uso terapéutico , Femenino , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/enzimología , Lóbulo Frontal/patología , Proteínas Ligadas a GPI/metabolismo , Dosificación Letal Mediana , Cloruro de Obidoxima/administración & dosificación , Cloruro de Obidoxima/uso terapéutico , Especificidad de Órganos , Organofosfatos/administración & dosificación , Oximas/administración & dosificación , Oximas/uso terapéutico , Compuestos de Piridinio/administración & dosificación , Compuestos de Piridinio/uso terapéutico , Ratas , Ratas Wistar , Formación Reticular/efectos de los fármacos , Formación Reticular/enzimología , Formación Reticular/patologíaRESUMEN
The potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to reactivate nerve agent-inhibited acetylcholinesterase was evaluated in rats poisoned with tabun or cyclosarin at a lethal dose corresponding to the LD50 value. In vivo determined percentage of reactivation of tabun-inhibited blood and brain acetylcholinesterase showed that obidoxime is the most efficacious reactivator of tabun-inhibited acetylcholinesterase among studied oximes in the peripheral compartment (blood) although the differences between obidoxime and newly developed oximes were not significant. On the other hand, one of the newly developed oximes (K074) seems to be a significantly more efficacious reactivator of tabun-inhibited acetylcholinesterase in the central compartment (brain) than the other studied oximes. In addition, the oxime HI-6 is unable to sufficiently reactivate tabun-inhibited acetylcholinesterase in rats. In vivo determined percentage of reactivation of cyclosarin-inhibited blood and brain acetylcholinesterase in poisoned rats showed that HI-6 is the most efficacious reactivator of cyclosarin-inhibited acetylcholinesterase among the studied oximes in the peripheral (blood) as well as central (brain) compartment although the differences between the oxime HI-6 and other tested oximes in the brain were not significant. Due to their reactivating effects, both newly developed K-oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisoning while the oximes HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings due to its high potency in reactivating cyclosarin-inhibited acetylcholinesterase in the peripheral as well as central compartment.
Asunto(s)
Antídotos/química , Antídotos/farmacología , Reactivadores de la Colinesterasa/química , Reactivadores de la Colinesterasa/farmacología , Oximas/química , Oximas/farmacología , Animales , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Butanos/química , Butanos/farmacología , Evaluación Preclínica de Medicamentos , Masculino , Cloruro de Obidoxima/química , Cloruro de Obidoxima/farmacología , Intoxicación por Organofosfatos , Organofosfatos/antagonistas & inhibidores , Compuestos Organofosforados/antagonistas & inhibidores , Compuestos de Piridinio/química , Compuestos de Piridinio/farmacología , Ratas , Ratas Wistar , Relación Estructura-ActividadRESUMEN
The mechanism of intoxication with organophosphorus compounds, including highly toxic nerve agents and less toxic pesticides, is based on the formation of irreversibly inhibited acetylcholinesterase, which causes cumulation of neuromediator acetylcholine in synaptic clefts and subsequent overstimulation of cholinergic receptors, that is followed by a generalized cholinergic crisis. Nerve agent poisoning is conventionally treated using a combination of a cholinolytic (atropine mostly) to counteract the accumulation of acetylcholine and acetylcholinesterase reactivators (pralidoxime or obidoxime) to reactivate inhibited acetylcholinesterase. In this study of cyclosarin poisoning treatment, oximes of different chemical structures (obidoxime, HI-6, BI-6, and HS-6) were tested in vitro on rat brain acetylcholinesterase (enzyme source: rat brain homogenate), and afterwards, they were tested in vivo in equimolar doses, in mice and rats. The HI-6 oxime appeared to be the most effective oxime in vitro and in vivo.
Asunto(s)
Inhibidores de la Colinesterasa/toxicidad , Reactivadores de la Colinesterasa/farmacología , Compuestos Organofosforados/toxicidad , Oximas/farmacología , Compuestos de Piridinio/farmacología , Animales , Antídotos/farmacología , Antídotos/uso terapéutico , Atropina/uso terapéutico , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Reactivadores de la Colinesterasa/uso terapéutico , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/toxicidad , Femenino , Técnicas In Vitro , Cinética , Dosificación Letal Mediana , Ratones , Antagonistas Muscarínicos/uso terapéutico , Cloruro de Obidoxima/farmacología , Cloruro de Obidoxima/uso terapéutico , Oximas/uso terapéutico , Compuestos de Piridinio/uso terapéutico , Ratas , Ratas WistarRESUMEN
Human poisoning by organophosphates bearing two methoxy groups, e.g. by malathion, paraoxon-methyl, dimethoate and oxydemeton-methyl, is generally considered to be rather resistant to oxime therapy. Since the oxime effectiveness is influenced not only by its reactivating potential but also by inhibition, aging and spontaneous reactivation kinetics, experiments were performed with human acetyl- (AChE) and butyrylcholinesterase (BChE) to determine the respective kinetic constants. The efficacy of obidoxime in reactivating dimethylphosphoryl-AChE was 40, 9 and 3 times higher than of HI 6, pralidoxime and HLö 7, respectively. Aging (t1/2 3.7 h) and spontaneous reactivation (t1/2 0.7 h) occurred concomitantly, with the portion of the aged enzyme being dependent on the presence of excess inhibitor. Calculation of steady-state AChE activity in the presence of inhibitor and oxime revealed that obidoxime was superior to pralidoxime. In addition, organophosphate concentrations up to 10(-6) M (paraoxon-methyl) and 10(-4) M (oxydemeton-methyl) could be counteracted at clinically relevant oxime concentrations (10 microM). These data indicate that oximes may effectively reactivate human dimethylphosphoryl-AChE. Failure of oximes may be attributed to megadose intoxications and to prolonged time intervals between poison uptake and oxime administration. The potency of the oximes to reactivate dimethylphosphoryl-BChE was much lower and the spontaneous reactivation slower (t1/2 9 h), while aging proceeded at a comparable rate. Thus, BChE activity determination for diagnosis and therapeutic monitoring may give no reliable information on AChE status.
Asunto(s)
Inhibidores de la Colinesterasa/farmacología , Colinesterasas/efectos de los fármacos , Compuestos Organofosforados/farmacología , Acetilcolinesterasa/sangre , Acetilcolinesterasa/efectos de los fármacos , Butirilcolinesterasa/sangre , Butirilcolinesterasa/efectos de los fármacos , Reactivadores de la Colinesterasa/farmacología , Colinesterasas/sangre , Humanos , Insecticidas/farmacología , Cinética , Cloruro de Obidoxima/farmacología , Compuestos Organotiofosforados/farmacología , Oximas/farmacología , Paraoxon/análogos & derivados , Paraoxon/farmacología , Compuestos de Pralidoxima/farmacología , Piridinas/farmacología , Compuestos de Piridinio/farmacología , Factores de TiempoRESUMEN
1 In vitro studies with human erythrocyte acetylcholinesterase (AChE) and the mouse diaphragm model were performed to unravel the various microscopic reaction parameters that contribute to the dynamic equilibrium of AChE inhibition, ageing and reactivation. These data may help to define more precisely the indications and limitations of oxime therapy in organophosphate (OP) poisoning. 2 Diethylphosphoryl-AChE resulting from intoxications with parathion, chlorpyrifos, chlorfenvinphos, diazinon and other OPs is characterized by slow spontaneous reactivation and low propensity for ageing. This kind of phosphorylated enzyme is particularly susceptible to reactivation by oximes. 3 None of the oximes tested (pralidoxime, obidoxime, HI 6 and HLö 7) can be regarded as a universally suitable reactivator. Obidoxime turned out to be the most potent and most efficacious oxime in reactivating AChE inhibited by various classes of OP insecticides and tabun. Obidoxime, however, was inferior to HI 6 against soman, sarin, cyclosarin and VX. Pralidoxime was generally less potent. 4 The kinetic data of reactivation established for diethylphosphoryl-AChE of human red cells indicate that the usually recommended dosage to attain a plasma concentration of 4 micrograms/ml does not permit exploitation of the full therapeutic potential of the oximes, in particular of pralidoxime. However, in suicidal mega-dose poisoning, oximes, even at optimal plasma concentrations, may be unable to cope with the fast re-inhibition of reactivated AChE in the first days following intoxication. 5 It is suggested that oximes be administered by continuous infusion following an initial bolus dose as long as reactivation can be expected and until permanent clinical improvement is achieved.
Asunto(s)
Antídotos/uso terapéutico , Intoxicación por Organofosfatos , Intoxicación/tratamiento farmacológico , Compuestos de Pralidoxima/uso terapéutico , Acetilcolinesterasa/metabolismo , Animales , Antídotos/administración & dosificación , Reactivadores de la Colinesterasa/farmacología , Membrana Eritrocítica/enzimología , Humanos , Ratones , Cloruro de Obidoxima/farmacología , Compuestos Organofosforados/química , Compuestos de Pralidoxima/administración & dosificaciónRESUMEN
The object of the study was to determine the pharmacological nature of pinacolyl methylphosphonofluoridate (soman)-induced hypothermia in mice. This was accomplished by examining the soman hypothermia dose response and the effect of various pharmacological antagonists in comparison to the hypothermia responses of muscarinic and nicotinic cholinergic agonists such as oxotremorine and nicotine and another anticholinesterase, physostigmine. Core temperature in mice was monitored by telemetry. In general, atropine antagonized oxotremorine, physostigmine, and soman hypothermia but not nicotine hypothermia whereas mecamylamine antagonized nicotine hypothermia but not that produced by the other agonists. Soman hypothermia was not affected significantly by various pharmacological antagonists, suggesting that other neurotransmitters were not involved in the expression of soman hypothermia. Soman hypothermia appears to be due to muscarinic receptor stimulation and can be effectively antagonized, but not completely, by the use of atropine. Acetylcholinesterase oxime reactivators, such as HI-6 and toxogonin, were ineffective in antagonizing soman-induced hypothermia and reactivating hypothalamic acetylcholinesterase, whereas HI-6 was effective in reactivating soman-inhibited diaphragm acetylcholinesterase when administered up to 10 min after soman, indicating that aging of the soman-inhibited acetylcholinesterase had not occurred. Soman hypothermia appears to be primarily a muscarinic receptor-related event.
Asunto(s)
Hipotermia/inducido químicamente , Soman/farmacología , Acetilcolinesterasa/metabolismo , Animales , Atropina/farmacología , Temperatura Corporal/efectos de los fármacos , Inhibidores de la Colinesterasa/farmacología , Reactivadores de la Colinesterasa/farmacología , Hipotálamo/efectos de los fármacos , Hipotálamo/enzimología , Hipotermia/fisiopatología , Masculino , Mecamilamina/farmacología , Ratones , Nicotina/antagonistas & inhibidores , Nicotina/farmacología , Cloruro de Obidoxima/farmacología , Oximas , Oxotremorina/antagonistas & inhibidores , Oxotremorina/farmacología , Fisostigmina/antagonistas & inhibidores , Fisostigmina/farmacología , Compuestos de Piridinio/farmacología , Soman/antagonistas & inhibidoresRESUMEN
Pyridine-2-aldoxime methiodide and pyridine-2-aldoxime methyl methane sulfonate (P2S) used as supplements to carbachol or neostigmine, greatly lowered the incidence of chicken embryos of vertebral defects and muscular hypoplasia. With 4-pyridine aldoxime the effect of the teratogens was less reduced. Supplementation of carbachol or neostigmine with either ambenonium or toxogonin lessened the occurrence of muscular hypoplasia, but did little, if anything, to prevent malformation of the neck vertebrae. In tests with physostigmine P2S as supplement reduced or prevented cervical defects, but failed to protect the nicotinamide-sensitive parts of the embryo.